Kyung Dong Pharmaceutical Co. Ltd Asset Resilience Ratio
Kyung Dong Pharmaceutical Co. Ltd asset resilience ratio. Kyung Dong Pharmaceutical Co. Ltd (011040) has an Asset Resilience Ratio of 4.72% as of June 2026. The Asset Resilience Ratio measures the percentage of a company's total assets that are held in liquid form (cash and short-term investments). This metric indicates how well-positioned the company is to handle unexpected financial challenges, economic downturns, or strategic opportunities without requiring external financing. See Kyung Dong Pharmaceutical Co. Ltd (011040) defensive interval to measure how many days the company can operate on defensive assets alone.
Liquid Assets
Total Assets
Resilience Assessment
Asset Resilience Ratio of Kyung Dong Pharmaceutical Co. Ltd (2011–2025)
Asset resilience ratio of Kyung Dong Pharmaceutical Co. Ltd from 2011 to 2025. This chart shows how Kyung Dong Pharmaceutical Co. Ltd's Asset Resilience Ratio has changed over time. Read Kyung Dong Pharmaceutical Co. Ltd (011040) financial obligations for a breakdown of total debt and financial obligations.
Liquid Assets Composition Over Time
This chart breaks down Kyung Dong Pharmaceutical Co. Ltd's liquid assets into cash & equivalents and short-term investments, showing how the composition has evolved over time. For the complete balance sheet picture, see balance sheet size of Kyung Dong Pharmaceutical Co. Ltd.
Current Liquid Assets Breakdown
| Component | Amount | % of Total Assets |
|---|---|---|
| Cash & Equivalents | ₩0.00 | 0% |
| Short-term Investments | ₩14.54 Billion | 4.72% |
| Total Liquid Assets | ₩14.54 Billion | 4.72% |
Asset Resilience Insights
- Limited Liquidity: Kyung Dong Pharmaceutical Co. Ltd maintains only 4.72% of assets in liquid form.
- This low level may indicate efficient asset utilization but could pose risks during economic downturns.
- The company has significant short-term investments, indicating active treasury management.
Kyung Dong Pharmaceutical Co. Ltd Industry Peers by Asset Resilience Ratio
Compare Kyung Dong Pharmaceutical Co. Ltd's asset resilience ratio with other companies in the same industry.
| Company | Industry | Asset Resilience Ratio |
|---|---|---|
|
GeneBioTech Co. Ltd
KQ:086060 |
Pharmaceuticals | 22.68% |
|
Sam Chun Dang Pharm. Co. Ltd
KQ:000250 |
Pharmaceuticals | 6.87% |
|
ST Pharm Co.Ltd
KQ:237690 |
Pharmaceuticals | 7.72% |
|
NatureCell Co.Ltd
KQ:007390 |
Pharmaceuticals | 0.00% |
|
Oscotec Inc
KQ:039200 |
Pharmaceuticals | 66.73% |
|
Komipharm International Co. Ltd
KQ:041960 |
Pharmaceuticals | 0.00% |
|
Mezzion Pharma Co.Ltd
KQ:140410 |
Pharmaceuticals | 0.00% |
|
Aprogen Healthcare & Games Inc
KQ:109960 |
Pharmaceuticals | 6.55% |
Kyung Dong Pharmaceutical Co. Ltd Asset Resilience Ratio by Year (2011–2025)
Kyung Dong Pharmaceutical Co. Ltd asset resilience ratio by year from 2011 to 2025. The table below shows the annual Asset Resilience Ratio data for Kyung Dong Pharmaceutical Co. Ltd.
| Year | Asset Resilience Ratio (%) | Liquid Assets | Total Assets | Change |
|---|---|---|---|---|
| 2025-12-31 | 4.72% | ₩15.19 Billion ≈ $10.29 Million |
₩321.90 Billion ≈ $218.14 Million |
-5.49pp |
| 2024-12-31 | 10.21% | ₩30.91 Billion ≈ $20.95 Million |
₩302.87 Billion ≈ $205.25 Million |
-0.74pp |
| 2023-12-31 | 10.95% | ₩32.07 Billion ≈ $21.74 Million |
₩292.97 Billion ≈ $198.54 Million |
-3.59pp |
| 2022-12-31 | 14.53% | ₩45.13 Billion ≈ $30.58 Million |
₩310.48 Billion ≈ $210.41 Million |
-2.61pp |
| 2021-12-31 | 17.14% | ₩50.04 Billion ≈ $33.91 Million |
₩291.97 Billion ≈ $197.87 Million |
-3.91pp |
| 2020-12-31 | 21.05% | ₩61.34 Billion ≈ $41.57 Million |
₩291.39 Billion ≈ $197.47 Million |
-5.41pp |
| 2019-12-31 | 26.46% | ₩76.09 Billion ≈ $51.56 Million |
₩287.59 Billion ≈ $194.90 Million |
-1.41pp |
| 2018-12-31 | 27.87% | ₩71.85 Billion ≈ $48.69 Million |
₩257.79 Billion ≈ $174.70 Million |
+6.14pp |
| 2017-12-31 | 21.74% | ₩54.65 Billion ≈ $37.03 Million |
₩251.43 Billion ≈ $170.39 Million |
-6.57pp |
| 2016-12-31 | 28.31% | ₩67.51 Billion ≈ $45.75 Million |
₩238.49 Billion ≈ $161.62 Million |
+15.70pp |
| 2015-12-31 | 12.61% | ₩29.43 Billion ≈ $19.94 Million |
₩233.41 Billion ≈ $158.18 Million |
-3.63pp |
| 2014-12-31 | 16.24% | ₩36.98 Billion ≈ $25.06 Million |
₩227.68 Billion ≈ $154.30 Million |
-5.99pp |
| 2013-12-31 | 22.24% | ₩44.56 Billion ≈ $30.20 Million |
₩200.39 Billion ≈ $135.80 Million |
-2.98pp |
| 2012-12-31 | 25.21% | ₩47.71 Billion ≈ $32.33 Million |
₩189.23 Billion ≈ $128.24 Million |
+3.30pp |
| 2011-12-31 | 21.91% | ₩40.69 Billion ≈ $27.57 Million |
₩185.72 Billion ≈ $125.86 Million |
-- |
About Kyung Dong Pharmaceutical Co. Ltd
Kyung Dong Pharmaceutical Co., Ltd. produces and sells specialized and general medicines in South Korea. It offers prescription medicines for liver therapy, antispasmodic, antidiabetic, antiviral, corticosteroid, androgen alopecia, muscle relaxant, antimigraine, vitamin, antifungal, endocrinal, urology, antibacterial, cardiovascular, pain/inflammation, smoking cessation aid, gastrointestinal, ant… Read more